Amie Doesn't Offer Kegel Reminders. It Rebuilds How Women's Bodies Get Supported Across Decades

The pelvic floor stretches to approximately 250 percent of its normal length during vaginal delivery. Most women receive a six-week postpartum check-up that lasts fifteen minutes and includes no internal examination. They are cleared for exercise without any assessment of diastasis recti, pelvic organ prolapse, or breathing mechanics. This is not malice. It is a system designed around episodic acute care rather than ongoing musculoskeletal support. Amie was founded to fill the gap that the medical system leaves open: continuous, adaptive care for women's bodies through pregnancy, postpartum, perimenopause, and everyday life.

Dr. Anna McMaster, a Doctor of Physical Therapy and certified Pelvic Rehabilitation Practitioner, spent a decade treating women who were told their symptoms were normal or imagined. Leaking urine during exercise. Pain with intercourse. Pelvic pressure that made standing uncomfortable. Abdominal separation that persisted years after delivery. Each patient had been dismissed by someone. McMaster built Amie to ensure that dismissal stops at the intake form. The platform combines a personalized exercise program that adapts in real time based on daily symptom tracking, virtual coaching sessions with licensed pelvic floor PTs, and direct text access to clinicians between appointments.

The revenue model is subscription-based. Members pay a recurring fee for ongoing access to their adaptive program, symptom tracking, educational content, and text-based clinician support. Virtual coaching sessions are available as add-on services for patients who want deeper guidance. The company is currently rebuilding its platform and operating a waitlist for new signups, suggesting a deliberate pause to scale infrastructure rather than a demand problem. Existing members retain full access during the rebuild.

The Adaptive Algorithm as a Clinical Scale Multiplier

Traditional physical therapy operates on a one-to-one model. A clinician sees a patient for 45 minutes, prescribes a home exercise program on paper, and hopes the patient follows through. The patient's condition changes between visits, but the prescription does not. Amie's platform inverts this model. Patients log symptoms daily through the app. Leaking more this week? The algorithm adjusts exercises toward greater pelvic floor activation. Feeling stronger? The program progresses to higher-impact movements. The adaptive algorithm allows a single clinician to manage a larger panel of patients because routine adjustments are automated. Clinical judgment is reserved for meaningful changes or escalations. This efficiency compresses the cost of care delivery, which supports a subscription price point that is accessible to patients who cannot afford $200-per-session outpatient PT.

The Symptom Tracking Layer as a Retention Engine

Digital health subscriptions churn when patients stop seeing value. Amie's symptom tracking layer functions as a progress visualization tool that reduces churn. A patient who logs daily leakage episodes sees a downward trend line after four weeks of consistent exercises. That visual proof of improvement is more compelling than abstract reassurance. The platform also uses tracking data to personalize messaging. A patient who misses three consecutive days of logging receives a different nudge than a patient who logs daily but reports worsening symptoms. Each interaction reinforces the subscription value. Churn is further reduced by the optional coaching sessions, which create episodic revenue spikes while deepening patient engagement with the core subscription.

The Direct Text Access as a Trust and Conversion Channel

Most direct-to-consumer women's health apps offer asynchronous messaging with non-clinical support staff. Amie offers direct text access to the patient's licensed physical therapist, with responses guaranteed within one business day. This feature is expensive to deliver. It requires clinician time and HIPAA-compliant messaging infrastructure. It is also the primary differentiator that converts free trial users to paid subscribers. A postpartum patient who can text her PT at 9 PM with a question about pelvic pressure will not cancel that subscription. The feature also generates clinical data: the questions patients ask between sessions reveal gaps in the educational content. Amie can close those gaps by updating its program library, reducing future messaging volume without reducing perceived access.

The Educational Content as a Top-of-Funnel Asset

Amie's blog publishes detailed, clinically accurate articles on topics that traditional women's health resources avoid or oversimplify. "Pooping After Birth: What No One Told You (But Should Have)." "Vaginal Estrogen Postpartum: What It Is and Why It Might Help." "Can I Prevent Diastasis Recti During Pregnancy?" Each article ranks for search queries that thousands of women type into Google at 2 AM while breastfeeding or unable to sleep from pelvic pain. The content costs little to produce McMaster writes from clinical experience and generates organic traffic that converts to waitlist signups. For a company rebuilding its platform, this content engine maintains brand presence and demand generation with zero paid acquisition spend.

The Waitlist as a Demand Signal and Product Validation Tool

Amie is currently paused for new signups while the platform undergoes a major rebuild. Existing members retain access, but new users join a waitlist. In most startup contexts, a pause signals trouble. In Amie's context, the waitlist functions as a demand validation tool and a product development buffer. The company can survey waitlisted users about feature priorities before rebuilding. It can estimate conversion rates from waitlist to paid subscription. It can launch the new platform to a warm audience that has already expressed intent, compressing the typical post-launch customer acquisition period. The pause also signals confidence: Amie is willing to forego short-term subscription revenue to build a more scalable, defensible product.

By 2026, women's health technology has moved beyond period tracking into clinical care delivery. The companies that survive this transition will not be those with the most polished apps but those with the strongest clinical foundations and the most adaptive platforms. Amie's foundation is a Doctor of Physical Therapy who treated patients for a decade before writing a line of code. That sequence clinical practice first, technology second is increasingly rare in a founder market dominated by MBAs who discovered a "problem" through secondary research. Amie does not claim to replace pelvic floor physical therapy. It claims to extend it into the days, weeks, and years between appointments. For the millions of women who were told their symptoms were normal, that extension is the product.

Dr. Anna McMaster, PT, DPT, PRPC, CEO & Founder

"I created Amie because I kept seeing the same problem: women needed ongoing support for their changing bodies, but care was too expensive, too inconvenient, or too hard to fit into real life."